Coronary artery disease (CAD) is the most common health problem worldwide and remains
the leading cause of morbidity and mortality. Over the past decade, it has become clear that …

The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and
mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are …

Background: Atheroregression becomes an attractive target for cardiovascular treatment.
Some clinical trials have demonstrated that intensive therapy with rosuvastatin or …

Atherosclerosis, the primary cause of cardiovascular disease (CVD), is a chronic
inflammatory disorder in the walls of medium and large arteries. CVD is currently …

The development of atherosclerosis (AS) is closely linked to changes in the plaque
microenvironment, which consists primarily of the cells that form plaque and the associated …

Mitochondria are of an increasing interest in pharmaceutical and medical research since it
has been reported that dysfunction of these organelles contributes to several diseases with …

Nanomedicine is emerging as a promising approach for diagnostic applications.
Nanoparticles are structures in the nanometer size range, which can present different …

Atherosclerosis (AS) is a chronic inflammatory vascular disease. Myocardial ischemia
originated from AS is the main cause of cardiovascular diseases, one of the major factors …

Atherosclerosis, the build-up of occlusive, lipid-rich plaques in arterial walls, is a focal trigger
of chronic coronary, intracranial, and peripheral arterial diseases, which together account for …